Alpha1-chimaerin, a Rac1 GTPase-activating protein, is expressed at reduced mRNA levels in the brain of Alzheimer's disease patients

被引:10
|
作者
Kato, Tomoko [1 ]
Konishi, Yoshihiro [2 ]
Shimohama, Shun [3 ]
Beach, Thomas G. [4 ]
Akatsu, Hiroyasu [5 ]
Tooyama, Ikuo [1 ]
机构
[1] Shiga Univ Med Sci, Mol Neurosci Res Ctr, Otsu, Shiga 5202192, Japan
[2] Nishi Tottori Natl Hosp, Dept Clin Res, Tottori 6890202, Japan
[3] Sapporo Med Univ, Dept Neurol, Sapporo, Hokkaido 0608556, Japan
[4] Banner Sun Hlth Res Inst, Sun City, AZ 85372 USA
[5] Nagoya City Univ, Grad Sch Med Sci, Dept Community Based Med Educ, Nagoya, Aichi 4678601, Japan
关键词
Alzheimer's disease; alpha; 1-chimaerin; Rac1; In situ hybridization; Real-time PCR; NEUROFIBRILLARY TANGLES; PYRAMIDAL NEURONS; NUCLEUS BASALIS; SPINE DENSITY; N-CHIMAERIN; KINASE; CDK5; HYPOTHESIS; INCREASES; PATHOLOGY;
D O I
10.1016/j.neulet.2015.02.013
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Alpha1-chimaerin is a GTPase-activating protein (GAP) for Rac1, a member of the Rho small GTPase family, whose action leads to the inactivation of Rac1. Rac1 activity is upregulated in Alzheimer's disease, but little is known about the role of alpha 1-chimaerin. In this study, we investigated the expression and localization of alpha 1-chimaerin mRNA in postmortem human brains from patients with Alzheimer's disease and control subjects. In situ hybridization studies demonstrated that alpha 1 -chimaerin was expressed by neurons in the neo-cortex of the temporal lobe and the hippocampus of both controls and Alzheimer's disease cases, with the signal intensity dramatically decreased in patients with Alzheimer's disease. Realtime PCR analysis confirmed a significant reduction of alpha 1-chimaerin mRNA expression in the temporal cortex of Alzheimer's disease cases. In contrast, alpha 2-chimaerin mRNA levels showed no significant difference between the groups. The present study showed reduced alpha 1-chimaerin expression in the brain of Alzheimer's disease cases, suggesting a role in the upregulation of Rac1 activity during the disease process. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:19 / 24
页数:6
相关论文
共 50 条
  • [41] Decreased levels of complex III core protein 1 and complex V β chain in brains from patients with Alzheimer's disease and Down syndrome
    Kim, SH
    Vlkolinsky, R
    Cairns, N
    Lubec, G
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2000, 57 (12) : 1810 - 1816
  • [42] Decreased levels of complex III core protein 1 and complex V β chain in brains from patients with Alzheimer’s disease and Down syndrome
    S. H. Kim
    R. Vlkolinsky
    N. Cairns
    G. Lubec*
    Cellular and Molecular Life Sciences CMLS, 2000, 57 : 1810 - 1816
  • [43] Stable cerebrospinal fluid neurogranin and β-site amyloid precursor protein cleaving enzyme 1 levels differentiate predementia Alzheimer's disease patients
    Kirsebom, Bjorn-Eivind
    Nordengen, Kaja
    Selnes, Per
    Waterloo, Knut
    Gisladottir, Berglind
    Brathen, Geir
    Aarsland, Dag
    Fladby, Tormod
    Richter, Grit
    Tijms, Betty M.
    Visser, Pieter Jelle
    Nilsson, Johanna
    Kramberger, Milica G.
    Winblad, Bengt
    Blennow, Kaj
    BRAIN COMMUNICATIONS, 2022, 4 (05)
  • [44] Fibroblasts from PS1 Mutated Pre-Symptomatic Subjects and Alzheimer's Disease Patients Share a Unique Protein Levels Profile
    Magini, Alessandro
    Urbanelli, Lorena
    Ciccarone, Virginia
    Tancini, Brunella
    Polidoro, Mario
    Timperio, Anna Maria
    Zolla, Lello
    Tedde, Andrea
    Sorbi, Sandro
    Emiliani, Carla
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 21 (02) : 431 - 444
  • [45] CAT 53: A protein phosphatase 1 nuclear targeting subunit encoded in the MHC Class I region strongly expressed in regions of the brain involved in memory, learning, and Alzheimer's disease
    Raha-Chowdhury, R
    Andrews, SR
    Gruen, JR
    MOLECULAR BRAIN RESEARCH, 2005, 138 (01): : 70 - 83
  • [46] Testing the Neurovascular Hypothesis of Alzheimer's Disease: LRP-1 Antisense Reduces Blood-Brain Barrier Clearance, Increases Brain Levels of Amyloid-β Protein, and Impairs Cognition
    Jaeger, Laura B.
    Dohgu, Shinya
    Hwang, Mark C.
    Farr, Susan A.
    Murphy, M. Paul
    Fleegal-DeMotta, Melissa A.
    Lynch, Jessica L.
    Robinson, Sandra M.
    Niehoff, Michael L.
    Johnson, Steven N.
    Kumar, Vijaya B.
    Banks, William A.
    JOURNAL OF ALZHEIMERS DISEASE, 2009, 17 (03) : 553 - 570
  • [47] Higher Levels of Oxidized Low Density Lipoproteins in Alzheimer's Disease Patients: Roles for Platelet Activating Factor Acetyl Hydrolase and Paraoxonase-1 (vol 46, pg 179, 2015)
    Bacchetti, Tiziana
    Vignini, Arianna
    Giulietti, Alessia
    Nanetti, Laura
    Provinciali, Leandro
    Luzzi, Simona
    Mazzanti, Laura
    Gianna
    JOURNAL OF ALZHEIMERS DISEASE, 2015, 47 (01) : 271 - 271
  • [48] Predictive Value of Cerebrospinal Fluid Visinin-Like Protein-1 Levels for Alzheimer's Disease Early Detection and Differential Diagnosis in Patients with Mild Cognitive Impairment
    Leko, Mirjana Babic
    Borovecki, Fran
    Dejanovic, Nenad
    Hof, Patrick R.
    Simic, Goran
    JOURNAL OF ALZHEIMERS DISEASE, 2016, 50 (03) : 765 - 778
  • [49] Changes of voltage-dependent anion-selective channel proteins VDAC1 and VDAC2 brain levels in patients with Alzheimer's disease and Down Syndrome
    Yoo, BC
    Fountoulakis, M
    Cairns, N
    Lubec, G
    ELECTROPHORESIS, 2001, 22 (01) : 172 - 179
  • [50] Exaggerated [Ca2+]I Signaling and Alzheimer's Disease-Like Phenotypes of PS1M146V Mice are Attenuated by Decreasing Brain InsP3R-1 Protein Levels
    Shilling, Dustin
    Muller, Marioly
    Takano, Hajime
    Mak, Don-On D.
    Abel, Ted
    Coulter, Doug
    Foskett, J. Kevin
    BIOPHYSICAL JOURNAL, 2013, 104 (02) : 121A - 121A